mPhase Technologies, Inc. (XDSL) Will Include Research and Development of Drug Delivery Systems to It's Path-Breaking Smart NanoBattery Technology  
6/25/2013 9:27:15 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LITTLE FALLS, New Jersey, June 24, 2013 /PRNewswire/ --

? mPhase Technologies, Inc. (OTCQB: XDSL) said today that is broadening it's focus on it's path-breaking battery technology to include research and development of Drug Delivery Systems.

In February of 2013 mPhase filed a United States Letter Patent Application for a novel drug delivery system based on its Smart Surface technology.

The drug delivery patent is based on mPhase's Smart Surface technology enabling the automatic dispensing of a pre set dosage of a drug agent or medication.

mPhase believes the research could lead to a novel drug delivery system possibly creating greater shareholder value.

Last week mPhase received the 2013 North America Frost & Sullivan Technology Innovation Award for its pioneering nanobattery technology.

About mPhase Technologies, Inc.

mPhase Technologies (OTCQB: XDSL) is a leading nanotechnology innovator in Smart Surfaces. Potential applications include energy storage systems, drug delivery systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.

In addition to the Smart Surface technology, mPhase, in collaboration with Porsche Design Studio, has developed a world class automotive jump starter. See More information about the company can be found at

Help employers find you! Check out all the jobs and post your resume.